These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33882273)

  • 1. New tetrahydroisoquinoline-based D
    Cordone P; Namballa HK; Muniz B; Pal RK; Gallicchio E; Harding WW
    Bioorg Med Chem Lett; 2021 Jun; 42():128047. PubMed ID: 33882273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Dopamine D3-Selective Receptor Ligands Containing a 6-Methoxy-1,2,3,4-tetrahydroisoquinolin-7-ol Motif.
    Gadhiya S; Cordone P; Pal RK; Gallicchio E; Wickstrom L; Kurtzman T; Ramsey S; Harding WW
    ACS Med Chem Lett; 2018 Oct; 9(10):990-995. PubMed ID: 30344905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands.
    Cao Y; Min C; Acharya S; Kim KM; Cheon SH
    Bioorg Med Chem; 2016 Jan; 24(2):191-200. PubMed ID: 26707842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure Activity Relationships for a Series of Eticlopride-Based Dopamine D
    Shaik AB; Boateng CA; Battiti FO; Bonifazi A; Cao J; Chen L; Chitsazi R; Ravi S; Lee KH; Shi L; Newman AH
    J Med Chem; 2021 Oct; 64(20):15313-15333. PubMed ID: 34636551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of σ Receptor Ligands with a Spirocyclic System Connected with a Tetrahydroisoquinoline Moiety via Different Linkers.
    Bergkemper M; Schepmann D; Wünsch B
    ChemMedChem; 2021 Apr; 16(7):1184-1197. PubMed ID: 33332704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of novel 1,2,3,4-tetrahydroisoquinoline derivatives and closely related compounds as potent and selective dopamine D3 receptor ligands.
    Mach UR; Hackling AE; Perachon S; Ferry S; Wermuth CG; Schwartz JC; Sokoloff P; Stark H
    Chembiochem; 2004 Apr; 5(4):508-18. PubMed ID: 15185375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Governing Selectivity of Dopamine Receptor Binding Compounds for D2R and D3R Subtypes.
    Hayatshahi HS; Luedtke RR; Taylor M; Chen PJ; Blass BE; Liu J
    J Chem Inf Model; 2021 Jun; 61(6):2829-2843. PubMed ID: 33988991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(3-fluoro-4-(4-(2-methoxy or 2,3-dichlorophenyl)piperazine-1-yl)butyl)arylcarboxamides as selective dopamine D3 receptor ligands: critical role of the carboxamide linker for D3 receptor selectivity.
    Banala AK; Levy BA; Khatri SS; Furman CA; Roof RA; Mishra Y; Griffin SA; Sibley DR; Luedtke RR; Newman AH
    J Med Chem; 2011 May; 54(10):3581-94. PubMed ID: 21495689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating isoindoline, tetrahydroisoquinoline, and tetrahydrobenzazepine scaffolds for their sigma receptor binding properties.
    Linkens K; Schmidt HR; Sahn JJ; Kruse AC; Martin SF
    Eur J Med Chem; 2018 May; 151():557-567. PubMed ID: 29656199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Novel Primary and Secondary Pharmacophores and 3-Substitution in the Linking Chain of a Series of Highly Selective and Bitopic Dopamine D
    Shaik AB; Kumar V; Bonifazi A; Guerrero AM; Cemaj SL; Gadiano A; Lam J; Xi ZX; Rais R; Slusher BS; Newman AH
    J Med Chem; 2019 Oct; 62(20):9061-9077. PubMed ID: 31526003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newly Developed Dopamine D
    Jordan CJ; Humburg BA; Thorndike EB; Shaik AB; Xi ZX; Baumann MH; Newman AH; Schindler CW
    J Pharmacol Exp Ther; 2019 Dec; 371(3):602-614. PubMed ID: 31562201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor.
    Adhikari P; Xie B; Semeano A; Bonifazi A; Battiti FO; Newman AH; Yano H; Shi L
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33924613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging a Low-Affinity Diazaspiro Orthosteric Fragment to Reduce Dopamine D
    Reilly SW; Riad AA; Hsieh CJ; Sahlholm K; Jacome DA; Griffin S; Taylor M; Weng CC; Xu K; Kirschner N; Luedtke RR; Parry C; Malhotra S; Karanicolas J; Mach RH
    J Med Chem; 2019 May; 62(10):5132-5147. PubMed ID: 31021617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands.
    Sun YT; Wang GF; Yang YQ; Jin F; Wang Y; Xie XY; Mach RH; Huang YS
    Eur J Med Chem; 2018 Mar; 147():227-237. PubMed ID: 29438891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of arylpiperazine-reverse amides as biased dopamine D3 receptor ligands.
    Cao Y; Paudel S; Zhang X; Kim KM; Cheon SH
    Bioorg Med Chem; 2015 Sep; 23(17):5264-72. PubMed ID: 26278029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selectivity and activation of dopamine D3R from molecular dynamics.
    Feng Z; Hou T; Li Y
    J Mol Model; 2012 Dec; 18(12):5051-63. PubMed ID: 22752545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects.
    Wager TT; Chappie T; Horton D; Chandrasekaran RY; Samas B; Dunn-Sims ER; Hsu C; Nawreen N; Vanase-Frawley MA; O'Connor RE; Schmidt CJ; Dlugolenski K; Stratman NC; Majchrzak MJ; Kormos BL; Nguyen DP; Sawant-Basak A; Mead AN
    ACS Chem Neurosci; 2017 Jan; 8(1):165-177. PubMed ID: 27715007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonists.
    Choi JK; Mandeville JB; Chen YI; Grundt P; Sarkar SK; Newman AH; Jenkins BG
    Psychopharmacology (Berl); 2010 Sep; 212(1):59-72. PubMed ID: 20628733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Pharmacological Characterization of Novel trans-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D
    Kumar V; Moritz AE; Keck TM; Bonifazi A; Ellenberger MP; Sibley CD; Free RB; Shi L; Lane JR; Sibley DR; Newman AH
    J Med Chem; 2017 Feb; 60(4):1478-1494. PubMed ID: 28186762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and Genetic Evidence of Dopamine Receptor 3-Mediated Vasoconstriction in Isolated Mouse Aorta.
    Zingales V; Torrisi SA; Leggio GM; Bucolo C; Drago F; Salomone S
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33799860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.